180 related articles for article (PubMed ID: 35941874)
1. How Dual-Energy Contrast-Enhanced Spectral Mammography Can Provide Useful Clinical Information About Prognostic Factors in Breast Cancer Patients: A Systematic Review of Literature.
Vasselli F; Fabi A; Ferranti FR; Barba M; Botti C; Vidiri A; Tommasin S
Front Oncol; 2022; 12():859838. PubMed ID: 35941874
[TBL] [Abstract][Full Text] [Related]
2. Deep learning analysis of contrast-enhanced spectral mammography to determine histoprognostic factors of malignant breast tumours.
Dominique C; Callonnec F; Berghian A; Defta D; Vera P; Modzelewski R; Decazes P
Eur Radiol; 2022 Jul; 32(7):4834-4844. PubMed ID: 35094119
[TBL] [Abstract][Full Text] [Related]
3. Intensity and Pattern of Enhancement on CESM: Prognostic Significance and its Relation to Expression of Podoplanin in Tumor Stroma - A Preliminary Report.
Luczynska E; Niemiec J; Heinze S; Adamczyk A; Ambicka A; Marcyniuk P; Rudnicki W; Mitus JW; Dyczek S; Rys J; Sas-Korczynska B
Anticancer Res; 2018 Feb; 38(2):1085-1095. PubMed ID: 29374745
[TBL] [Abstract][Full Text] [Related]
4. Radiomic Analysis in Contrast-Enhanced Spectral Mammography for Predicting Breast Cancer Histological Outcome.
La Forgia D; Fanizzi A; Campobasso F; Bellotti R; Didonna V; Lorusso V; Moschetta M; Massafra R; Tamborra P; Tangaro S; Telegrafo M; Pastena MI; Zito A
Diagnostics (Basel); 2020 Sep; 10(9):. PubMed ID: 32957690
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of contrast-enhanced dual-energy spectral mammography (CESM): a retrospective study involving 644 breast lesions.
Travieso-Aja MDM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Vega Benítez V; Pérez-Luzardo O
Radiol Med; 2019 Oct; 124(10):1006-1017. PubMed ID: 31250270
[TBL] [Abstract][Full Text] [Related]
6. Classification of contrast-enhanced spectral mammography (CESM) images.
Perek S; Kiryati N; Zimmerman-Moreno G; Sklair-Levy M; Konen E; Mayer A
Int J Comput Assist Radiol Surg; 2019 Feb; 14(2):249-257. PubMed ID: 30367322
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefits.
Houben IPL; Van de Voorde P; Jeukens CRLPN; Wildberger JE; Kooreman LF; Smidt ML; Lobbes MBI
Eur J Radiol; 2017 Sep; 94():31-37. PubMed ID: 28941757
[TBL] [Abstract][Full Text] [Related]
8. Correlation between quantitative assessment of contrast enhancement in contrast-enhanced spectral mammography (CESM) and histopathology-preliminary results.
Rudnicki W; Heinze S; Niemiec J; Kojs Z; Sas-Korczynska B; Hendrick E; Luczynska E
Eur Radiol; 2019 Nov; 29(11):6220-6226. PubMed ID: 31089850
[TBL] [Abstract][Full Text] [Related]
9. Degree of Enhancement on Contrast Enhanced Spectral Mammography (CESM) and Lesion Type on Mammography (MG): Comparison Based on Histological Results.
Łuczyńska E; Niemiec J; Hendrick E; Heinze S; Jaszczyński J; Jakubowicz J; Sas-Korczyńska B; Rys J
Med Sci Monit; 2016 Oct; 22():3886-3893. PubMed ID: 27768681
[TBL] [Abstract][Full Text] [Related]
10. Analysis of background parenchymal enhancement (BPE) on contrast enhanced spectral mammography compared with magnetic resonance imaging.
Luczynska E; Pawlak M; Piegza T; Popiela TJ; Heinze S; Dyczek S; Rudnicki W
Ginekol Pol; 2021; 92(2):92-97. PubMed ID: 33448005
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced spectral mammography: A potential exclusion diagnosis modality in dense breast patients.
Qin Y; Liu Y; Zhang X; Zhao S; Zhong H; Huang J; Yu J
Cancer Med; 2020 Apr; 9(8):2653-2659. PubMed ID: 32074407
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Assessment of Contrast Enhancement on Contrast Enhancement Spectral Mammography (CESM) and Comparison With Qualitative Assessment.
Rudnicki W; Heinze S; Popiela T; Kojs Z; Luczynska E
Anticancer Res; 2020 May; 40(5):2925-2932. PubMed ID: 32366444
[TBL] [Abstract][Full Text] [Related]
14. Correlation Between Enhancement Intensity in Contrast Enhancement Spectral Mammography and Types of Kinetic Curves in Magnetic Resonance Imaging.
Rudnicki W; Heinze S; Piegza T; Pawlak M; Kojs Z; Łuczyńska E
Med Sci Monit; 2020 Mar; 26():e920742. PubMed ID: 32173716
[TBL] [Abstract][Full Text] [Related]
15. Develop and Validate a Nomogram Combining Contrast-Enhanced Spectral Mammography Deep Learning with Clinical-Pathological Features to Predict Neoadjuvant Chemotherapy Response in Patients with ER-Positive/HER2-Negative Breast Cancer.
Xing D; Lv Y; Sun B; Chu T; Bao Q; Zhang H
Acad Radiol; 2024 Apr; ():. PubMed ID: 38641451
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Accuracy of Contrast-Enhanced, Spectral Mammography (CESM) and 3T Magnetic Resonance Compared to Full-Field Digital Mammography plus Ultrasound in Breast Lesions: Results of a (Pilot) Open-Label, Single-Centre Prospective Study.
Ferranti FR; Vasselli F; Barba M; Sperati F; Terrenato I; Graziano F; Vici P; Botti C; Vidiri A
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267659
[TBL] [Abstract][Full Text] [Related]
17. Radiomic Features Applied to Contrast Enhancement Spectral Mammography: Possibility to Predict Breast Cancer Molecular Subtypes in a Non-Invasive Manner.
Nicosia L; Bozzini AC; Ballerini D; Palma S; Pesapane F; Raimondi S; Gaeta A; Bellerba F; Origgi D; De Marco P; Castiglione Minischetti G; Sangalli C; Meneghetti L; Curigliano G; Cassano E
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499648
[TBL] [Abstract][Full Text] [Related]
18. Association between lesion enhancement and breast cancer in contrast-enhanced spectral mammography.
Boy FNS; Goksu K; Tasdelen I
Acta Radiol; 2023 Jan; 64(1):74-79. PubMed ID: 34854742
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour size.
Fallenberg EM; Dromain C; Diekmann F; Engelken F; Krohn M; Singh JM; Ingold-Heppner B; Winzer KJ; Bick U; Renz DM
Eur Radiol; 2014 Jan; 24(1):256-64. PubMed ID: 24048724
[TBL] [Abstract][Full Text] [Related]
20. Dual-Energy Contrast-Enhanced Spectral Mammography: Enhancement Analysis on BI-RADS 4 Non-Mass Microcalcifications in Screened Women.
Cheung YC; Juan YH; Lin YC; Lo YF; Tsai HP; Ueng SH; Chen SC
PLoS One; 2016; 11(9):e0162740. PubMed ID: 27611215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
